This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow E-mail this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Jenks, P. J.
Right arrow Articles by Ferrero, R. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Jenks, P. J.
Right arrow Articles by Ferrero, R. L.

 Previous Article  |  Next Article 

Antimicrobial Agents and Chemotherapy, April 1999, p. 777-781, Vol. 43, No. 4
0066-4804/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.

Exposure to Metronidazole In Vivo Readily Induces Resistance in Helicobacter pylori and Reduces the Efficacy of Eradication Therapy in Mice

Peter J. Jenks,* Agnes Labigne, and Richard L. Ferrero

Unité de Pathogénie Bactérienne des Muqueuses, Institut Pasteur, 75724 Paris Cedex 15, France

Received 9 October 1998/Returned for modification 25 November 1998/Accepted 25 January 1999

The Helicobacter pylori SS1 mouse model was used to characterize the development of resistance in H. pylori after treatment with metronidazole monotherapy and to examine the effect of prior exposure to metronidazole on the efficacy of a metronidazole-containing eradication regimen. Mice colonized with the metronidazole-sensitive H. pylori SS1 strain were treated for 7 days with either peptone trypsin broth or the mouse equivalent of 400 mg of metronidazole once a day or three times per day (TID). In a separate experiment, H. pylori-infected mice were administered either peptone trypsin broth or the mouse equivalent of 400 mg of metronidazole TID for 7 days, followed 1 month later by either peptone trypsin broth or the mouse equivalent of 20 mg of omeprazole, 250 mg of clarithromycin, and 400 mg of metronidazole twice a day for 7 days. At least 1 month after the completion of treatment, the mice were sacrificed and their stomachs were cultured for H. pylori. The susceptibilities of isolates to metronidazole were assessed by agar dilution determination of the MICs. Mixed populations of metronidazole-resistant and -sensitive strains were isolated from 70% of mice treated with 400 mg of metronidazole TID. The ratio of resistant to sensitive strains was 1:100, and the MICs for the resistant strains varied from 8 to 64 µg/ml. In the second experiment, H. pylori was eradicated from 70% of mice treated with eradication therapy alone, compared to 25% of mice pretreated with metronidazole (P < 0.01). Mice still infected after treatment with metronidazole and eradication therapy contained mixed populations of metronidazole-resistant and -sensitive isolates in a ratio of 1:25. These results demonstrate that H. pylori readily acquires resistance to metronidazole in vivo and that prior exposure of the organism to metronidazole is associated with failure of eradication therapy. H. pylori-infected mice provide a suitable model for the study of resistance mechanisms in H. pylori and will be useful in determining optimal regimens for the eradication of resistant strains.

* Corresponding author. Mailing address: Unité de Pathogénie Bactérienne des Muqueuses, Institut Pasteur, 28 Rue du Dr Roux, 75724 Paris Cedex 15, France. Phone: 33-1-40613272. Fax: 33-1-40613640. E-mail: pjenks{at}pasteur.fr.

Antimicrobial Agents and Chemotherapy, April 1999, p. 777-781, Vol. 43, No. 4
0066-4804/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.


This article has been cited by other articles:

  • Paraschos, S., Magiatis, P., Mitakou, S., Petraki, K., Kalliaropoulos, A., Maragkoudakis, P., Mentis, A., Sgouras, D., Skaltsounis, A.-L. (2007). In Vitro and In Vivo Activities of Chios Mastic Gum Extracts and Constituents against Helicobacter pylori. Antimicrob. Agents Chemother. 51: 551-559 [Abstract] [Full Text]  
  • Gerrits, M. M, van der Wouden, E.-J., Bax, D. A, van Zwet, A. A, van Vliet, A. H., de Jong, A., Kusters, J. G, Thijs, J. C, Kuipers, E. J (2004). Role of the rdxA and frxA genes in oxygen-dependent metronidazole resistance of Helicobacter pylori. J Med Microbiol 53: 1123-1128 [Abstract] [Full Text]  
  • Elviss, N. C., Owen, R. J., Xerry, J., Walker, A. M., Davies, K. (2004). Helicobacter pylori antibiotic resistance patterns and genotypes in adult dyspeptic patients from a regional population in North Wales. J Antimicrob Chemother 54: 435-440 [Abstract] [Full Text]  
  • Lui, S.-Y., Yeoh, K.-G., Ho, B. (2003). Metronidazole-Resistant Helicobacter pylori Is More Prevalent in Patients with Nonulcer Dyspepsia than in Peptic Ulcer Patients in a Multiethnic Asian Population. J. Clin. Microbiol. 41: 5011-5014 [Abstract] [Full Text]  
  • van Zanten, S. J. O. V., Kolesnikow, T., Leung, V., O'Rourke, J. L., Lee, A. (2003). Gastric Transitional Zones, Areas where Helicobacter Treatment Fails: Results of a Treatment Trial Using the Sydney Strain Mouse Model. Antimicrob. Agents Chemother. 47: 2249-2255 [Abstract] [Full Text]  
  • Loughlin, M. F., Barnard, F. M., Jenkins, D., Sharples, G. J., Jenks, P. J. (2003). Helicobacter pylori Mutants Defective in RuvC Holliday Junction Resolvase Display Reduced Macrophage Survival and Spontaneous Clearance from the Murine Gastric Mucosa. Infect. Immun. 71: 2022-2031 [Abstract] [Full Text]  
  • Loughlin, M. F., Ala'Aldeen, D. A., Jenks, P. J. (2003). Monotherapy with mastic does not eradicate Helicobacter pylori infection from mice. J Antimicrob Chemother 51: 367-371 [Abstract] [Full Text]  
  • Latham, S. R., Labigne, A., Jenks, P. J. (2002). Production of the RdxA protein in metronidazole-susceptible and -resistant isolates of Helicobacter pylori cultured from treated mice. J Antimicrob Chemother 49: 675-678 [Abstract] [Full Text]  
  • Latham, S. R., Owen, R. J., Elviss, N. C., Labigne, A., Jenks, P. J. (2001). Differentiation of Metronidazole-Sensitive and -Resistant Clinical Isolates of Helicobacter pylori by Immunoblotting with Antisera to the RdxA Protein. J. Clin. Microbiol. 39: 3052-3055 [Abstract] [Full Text]  
  • Jeong, J.-Y., Mukhopadhyay, A. K., Akada, J. K., Dailidiene, D., Hoffman, P. S., Berg, D. E. (2001). Roles of FrxA and RdxA Nitroreductases of Helicobacter pylori in Susceptibility and Resistance to Metronidazole. J. Bacteriol. 183: 5155-5162 [Abstract] [Full Text]  
  • Wang, G., Wilson, T. J. M., Jiang, Q., Taylor, D. E. (2001). Spontaneous Mutations That Confer Antibiotic Resistance in Helicobacter pylori. Antimicrob. Agents Chemother. 45: 727-733 [Abstract] [Full Text]  
  • Touati, E., Hofnung, M., Thiberge, J.-M., Michel, V., Labigne, A., Jenks, P. J. (2000). Short-term infection with Helicobacter pylori and 1 week exposure to metronidazole does not enhance gastric mutation frequency in transgenic mice. J Antimicrob Chemother 46: 987-992 [Abstract] [Full Text]  
  • Jeong, J.-Y., Berg, D. E. (2000). Mouse-Colonizing Helicobacter pylori SS1 Is Unusually Susceptible to Metronidazole Due to Two Complementary Reductase Activities. Antimicrob. Agents Chemother. 44: 3127-3132 [Abstract] [Full Text]  
  • Jenks, P. J., Ferrero, R. L., Tankovic, J., Thiberge, J.-M., Labigne, A. (2000). Evaluation of Nitrofurantoin Combination Therapy of Metronidazole-Sensitive and -Resistant Helicobacter pylori Infections in Mice. Antimicrob. Agents Chemother. 44: 2623-2629 [Abstract] [Full Text]  
  • Sisson, G., Jeong, J.-Y., Goodwin, A., Bryden, L., Rossler, N., Lim-Morrison, S., Raudonikiene, A., Berg, D. E., Hoffman, P. S. (2000). Metronidazole Activation Is Mutagenic and Causes DNA Fragmentation in Helicobacter pylori and in Escherichia coli Containing a Cloned H. pylori rdxA+ (Nitroreductase) Gene. J. Bacteriol. 182: 5091-5096 [Abstract] [Full Text]  
  • Tankovic, J., Lamarque, D., Delchier, J.-C., Soussy, C.-J., Labigne, A., Jenks, P. J. (2000). Frequent Association between Alteration of the rdxA Gene and Metronidazole Resistance in French and North African Isolates of Helicobacter pylori. Antimicrob. Agents Chemother. 44: 608-613 [Abstract] [Full Text]  


Copyright © 2010 by the American Society for Microbiology.   For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»